Autoantibodies Neutralizing Type III Interferons Are Uncommon in Patients with Severe Coronavirus Disease 2019 Pneumonia
Martti Vanker(University of Tartu), Sean Knight(Manchester Academic Health Science Centre), Paul Bastard(Inserm), Anne Kallaste(Tartu University Hospital), Liis Haljasmägi(University of Tartu), Quentin Philippot(Inserm), Sofie E. Jørgensen(Aarhus University), Margus Lember(Tartu University Hospital), Tracy Hussell(Manchester Academic Health Science Centre), Qian Zhang(Cixian People's Hospital), Madhvi Menon(University of Manchester), Trine H. Mogensen(Aarhus University), Pärt Peterson(University of Tartu), Anne Puel(Inserm), Arnaud Fekkar(Inserm), Shen‐Ying Zhang(Inserm), Kalle Kisand(University of Tartu), Kai Kisand(University of Tartu), James Oscar Moore-Stanley(Inserm), Karita Särekannu(Institute of Clinical Research), Jean-Laurent Casanova(Howard Hughes Medical Institute)
Cited by 30
Related Papers
TLR3 Deficiency in Patients with Herpes Simplex Encephalitis
|Science|2007|1.1k
Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I
|The Journal of Experimental Medicine|2010|721